Circulating antiganglioside antibodies are not associated with the development of progressive disease or cerebral atrophy in patients with multiple sclerosis.
Giovannoni
G
G
Morris
P R
PR
Keir
G
G
D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D001284:Atrophy / Q000276:immunology / Q000473:pathology; D001921:Brain / Q000276:immunology / Q000473:pathology; D018450:Disease Progression; D005732:Gangliosides / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000276:immunology* / Q000473:pathology*
D000888:Antibodies, Anti-Idiotypic; D005732:Gangliosides; D007074:Immunoglobulin G; D007075:Immunoglobulin M